Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682
1 Population Health and Genomics, School of Medicine, University of Dundee, Dundee, U.K.
2 Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA.
3 Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
4 Genomic Medicine Institute, Geisinger, Danville, PA.
5 Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
6 Division of Research, Kaiser Permanente Northern California, Oakland, CA.
7 Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA.
8 Programs in Metabolism and Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA.
9 Amsterdam UMC, location VUmc, Department of General Practice, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
10 Amsterdam UMC, location VUmc, Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
11 Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands.
12 Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.
13 RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
14 Department of Medicine, Harvard Medical School, Boston, MA.
15 Section Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
16 Department of General Practice Medicine, Amsterdam Public Health Research Institute, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
17 Institute for Human Genetics, University of California, San Francisco, San Francisco, CA.